Injectable Nospa (Drotaverine) Dosing for Acute Abdominal Pain in Adults
The recommended adult dose of injectable Nospa (drotaverine hydrochloride) for acute abdominal pain is 40-80 mg administered intramuscularly or intravenously, which may be repeated if necessary, with a maximum daily dose not exceeding 240 mg.
Evidence-Based Dosing Protocol
The dosing for injectable drotaverine in acute abdominal pain is derived from clinical research rather than the provided FDA label (which appears to be for a different nasal formulation 1). Based on high-quality clinical trials:
Standard Dosing Regimen
- Initial dose: 40-80 mg IV or IM
- Route: Intravenous or intramuscular administration
- Repeat dosing: May repeat once after 30-40 minutes if pain relief is inadequate 2
- Maximum daily dose: 240 mg total
Clinical Context and Efficacy
For renal/ureteric colic: A multicenter, randomized, double-blind trial demonstrated that 80 mg IV drotaverine (with option to repeat once) provided effective pain relief in 79% of patients within 40 minutes, compared to 46% with placebo (P < 0.001) 2. A comparative study showed 80 mg IM drotaverine achieved 52.4% pain reduction at 30 minutes and 61.3% at 60 minutes, with efficacy non-inferior to diclofenac 75 mg 3.
For acute infectious gastroenteritis with abdominal pain: Fixed-dose combination of drotaverine 80 mg with paracetamol 500 mg given orally three times daily showed superior pain relief compared to paracetamol alone, with onset of pain relief within 60 minutes 4.
Practical Administration Guidelines
Timing and Monitoring
- Assess pain intensity using Visual Analogue Scale (VAS) before administration
- Re-evaluate at 30-40 minutes post-injection
- If pain reduction is <50%, consider repeat dose (second 80 mg injection)
- Monitor for 2 hours after last dose to ensure sustained relief
Safety Profile
The most common side effects are minor and transient 2:
- Temporary decrease in blood pressure (monitor in hemodynamically unstable patients)
- Vertigo
- Nausea or vomiting
- No serious adverse effects reported in clinical trials
When to Use Drotaverine
Drotaverine is particularly effective for:
- Smooth muscle spasm-related pain: Renal colic, biliary colic, intestinal colic
- Acute gastroenteritis with cramping pain 4
- Irritable bowel syndrome exacerbations 5
Contraindications and Cautions
- Avoid in severe hepatic or renal impairment
- Use caution in patients with cardiovascular instability
- Not recommended as monotherapy for surgical emergencies requiring intervention
Clinical Decision Algorithm
Confirm diagnosis: Ensure abdominal pain is from smooth muscle spasm (colicky, cramping quality) rather than peritonitis or surgical emergency 6
Initial injection: Administer 40-80 mg IV/IM (80 mg preferred for moderate-severe pain)
Assess at 30-40 minutes:
- If ≥50% pain reduction → observe for recurrence
- If <50% pain reduction → administer second 80 mg dose
Consider rescue analgesia: If inadequate relief after two doses, add tramadol 100 mg IM or alternative analgesic 3
Do not exceed: 240 mg total daily dose
Important caveat: While drotaverine is highly effective for spasmodic abdominal pain, it does not address underlying pathology. Patients with acute abdominal pain require appropriate diagnostic workup (imaging, laboratory studies) to exclude surgical emergencies such as appendicitis, bowel obstruction, or perforation 6. Drotaverine provides symptomatic relief while diagnostic evaluation proceeds, but should never delay necessary surgical intervention.